ethyl (4R)-6-(bromomethyl)-4-(4-cyanophenyl)-3-[3-[(2-methylpropan-2-yl)oxycarbonylamino]propyl]-2-oxo-1-[3-(trifluoromethyl)phenyl]-4H-pyrimidine-5-carboxylate | 956487-23-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: ethyl (4R)-6-(bromomethyl)-4-(4-cyanophenyl)-3-[3-[(2-methylpropan-2-yl)oxycarbonylamino]propyl]-2-oxo-1-[3-(trifluoromethyl)phenyl]-4H-pyrimidine-5-carboxylate
• CAS: 956487-23-3
• 化学式: C₃₀H₃₂BrF₃N₄O₅
• 分子量: 665.507
• InChiKey: AHJAUOCFKMAREZ-RUZDIDTESA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.2
• 重原子数：
  43
• 可旋转键数：
  12
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  112
• 氢给体数：
  1
• 氢受体数：
  9

反应信息

• 作为反应物：
  描述：

  ethyl (4R)-6-(bromomethyl)-4-(4-cyanophenyl)-3-[3-[(2-methylpropan-2-yl)oxycarbonylamino]propyl]-2-oxo-1-[3-(trifluoromethyl)phenyl]-4H-pyrimidine-5-carboxylate 在 碳酸氢钠 、 三氟乙酸 、 碘甲烷 作用下， 以 四氢呋喃 、 industrial methylated spirits 、 二氯甲烷 、 乙腈 为溶剂， 反应 173.75h， 生成 C₅₁H₄₇F₆N₁₁O₄
  参考文献：
  名称：

  WO2007/129060

  摘要：

  公开号：
• 作为产物：
  描述：

  N-Boc-3-氨基丙基溴 在 N-溴代丁二酰亚胺(NBS) 、 sodium hydride 作用下， 以 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 4.0h， 生成 ethyl (4R)-6-(bromomethyl)-4-(4-cyanophenyl)-3-[3-[(2-methylpropan-2-yl)oxycarbonylamino]propyl]-2-oxo-1-[3-(trifluoromethyl)phenyl]-4H-pyrimidine-5-carboxylate
  参考文献：
  名称：

  WO2007/129060

  摘要：

  公开号：

文献信息

• [EN] TETRAHYDROPYRROLOPYRIMIDINEDIONES AND THEIR USE AS HUMAN NEUTROPHIL ELASTASE INHIBITORS<br/>[FR] TÉTRAHYDROPYRROLOPYRIMIDINEDIONES ET LEUR UTILISATION COMME INHIBITEURS DE L'ÉLASTASE DES NEUTROPHILES HUMAINS
  申请人：ARGENTA DISCOVERY LTD

  公开号：WO2009013444A1

  公开（公告）日：2009-01-29

  Compounds of formula (I) and multimers thereof are inhibitors of human neutrophil elastase activity, and of utility in the treatment of, e.g., COPD : wherein all the substituents are as defined in claim 1.

  式（I）的化合物及其多聚体是人类中性粒细胞弹性蛋白酶活性的抑制剂，并且在治疗COPD等方面具有实用价值：其中所有取代基均如权利要求1所定义。
• TETRAHYDROPYRROLOPYRIMIDINEDIONES AND THEIR USE IN THERAPY
  申请人：RAY Nicholas Charles

  公开号：US20090093477A1

  公开（公告）日：2009-04-09

  Compounds of formula (I) and multimers thereof are inhibitors of human neutrophil elastase activity, and of utility in the treatment of, e.g., COPD: wherein A is aryl or heteroaryl; D is oxygen or sulphur; R 1 , R 2 and R 3 are independently each hydrogen, halogen, nitro, cyano, C 1 -C 6 -alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, hydroxy or C 1 -C 6 -alkoxy or C 2 -C 6 -alkenyloxy, wherein C 1 -C 6 -alkyl and C 1 -C 6 -alkoxy can be further substituted with one to three identical or different radicals selected from the group consisting of halogen, hydroxy and C 1 -C 4 -alkoxy; R and R 4 each independently represent a radical of formula —[X] m -[Alk 1 ] p -[Q] n -[Alk 2 ] q -[X 1 ] k -Z wherein k, m, n, p and q are independently 0 or 1; Alk 1 and Alk 2 each independently represent an optionally substituted C 1 -C 6 alkylene, or C 2 -C 6 alkenylene radical which may optionally contain an ether (O—), thioether (—S—) or amino (—NR A —) link wherein R A is hydrogen or C 1 -C 3 alkyl; Q represents (i) O—, —S—, —S(═O)—, —S(═O) 2 —, —S + (R A )—, —N(R A )—, —N + (R A )(R B )—, —C(═O)—, —C(═O)O—, —OC(═O)—, —C(═O)NR A —, —NR A C(═O)—, —S(O 2 )NR A —, —NR A S(O 2 )—, —NR A C(═O)NR B —, —NR A C(═NR A )NR B —, —C(═NR D )NR E , —NR E C(═NR D ), wherein R A , R B , R D and R E are independently hydrogen, C 1 -C 6 alkyl, or C 3 -C 6 cycloalkyl, or R A and R B , or R D and R E taken together with the nitrogen to which they are attached form a monocyclic heterocyclic ring of 5 to 7 ring atoms which my contain a further heteroatom selected from N, O and S, or (ii) an optionally substituted divalent mono- or bicyclic carbocyclic or heterocyclic radical having 3-6 ring members; X represents —(C═O)—, —S(O 2 )—, —C(═O)O—, —(C═O)NR A —, or —S(O 2 )NR A —, wherein R A is hydrogen, C 1 -C 6 alkyl, or C 3 -C 6 cycloalkyl; X 1 represents —O—, —S—, or —NH; and Z is hydrogen or an optionally substituted mono- or bicyclic carbocyclic or heterocyclic radical having 3-6 ring members.
• Tetrahydropyrrolopyrimidinediones And Their Use In Therapy
  申请人：RAY Nicholas Charles

  公开号：US20120202826A1

  公开（公告）日：2012-08-09

  The subject invention provides compounds of formula (I): Including monomers and multimers thereof that are inhibitors of human neutrophil elastase (HNE) activity and are useful in the treatment of diseases or conditions in which HNE plays a part.
• US8198288B2
  申请人：——

  公开号：US8198288B2

  公开（公告）日：2012-06-12
• US8957082B2
  申请人：——

  公开号：US8957082B2

  公开（公告）日：2015-02-17